<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="30353">Isopropyl</z:chebi>(2-<z:chebi fb="8" ids="32772">methoxy</z:chebi>-ethyl) 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-<z:chebi fb="0" ids="36173">pyridinedicarboxylate</z:chebi> (Bay e 9736, nimodipine) is a calcium antagonistic <z:chebi fb="0" ids="50075">dihydropyridine</z:chebi> derivative with a preferential effect on cerebral vessels </plain></SENT>
<SENT sid="1" pm="."><plain>It dilates cerebral vessels in several species after intraarterial, intravenous, perlingual, and oral administration in low dosage </plain></SENT>
<SENT sid="2" pm="."><plain>Its effect on the peripheral blood vessels is less pronounced so that nimodipine increases cerebral blood flow without substantial decrease of blood pressure </plain></SENT>
<SENT sid="3" pm="."><plain>Nimodipine does not inhibit carbonic anhydrase and does not stimulate the oxygen consumption of brain tissue in vitro </plain></SENT>
<SENT sid="4" pm="."><plain>Its effect is not influenced by <z:chebi fb="2" ids="8499">propranolol</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>Therefore its cerebral vasodilating effect is due to its direct relaxing effect on vascular smooth muscle </plain></SENT>
<SENT sid="6" pm="."><plain>Nimodipine prevents the postischaemic impaired cerebral reperfusion in cats </plain></SENT>
<SENT sid="7" pm="."><plain>Transient global <z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">cerebral ischaemia</z:e> increases the cerebrovascular resistance to flow by means of the increase in extracellular concentration of <z:chebi fb="3" ids="29103">potassium ions</z:chebi> </plain></SENT>
<SENT sid="8" pm="."><plain>Such depolarization produces sustained cerebral vasoconstriction presumably by enhancing transmembrane influx of calcium </plain></SENT>
<SENT sid="9" pm="."><plain>Nimodipine does not influence the ischaemic increase in Ko+ ions but effectively prevents the postischaemic <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebrovascular spasm</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>From its pharmacological properties nimodipine is predicted to be effective in the prevention and therapy of <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebrovascular spasm</z:e> of various origins and especially in the treatment of postischaemic brain damage </plain></SENT>
</text></document>